Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal

키워드

참고문헌 (54)

1. Bonow RO, "2008 Focused update incorporated into the ACC", AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology, Circulation, pp.2008, 118[DOI]
2. Goette A, "Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression", Circulation, 117, pp.732~742 (2008)
3. Di Biase L, "Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study", J Am Coll Cardiol, 60, pp.531~538 (2012)
4. Al-Saady NM, "Left atrial appendage: structure, function, and role in thromboembolism", Heart, 82, pp.547~554 (1999)
5. Blackshear JL, "Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation", Ann Thorac Surg, 61, pp.755~759 (1996)
6. Mahajan R, "Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure", Heart, 98, pp.1120~1126 (2012)
7. Kimura T, "Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores", Heart Rhythm, 10, pp.921~925 (2013)
8. Johnson WD, "The left atrial appendage: our most lethal human attachment! Surgical implications", Eur J Cardiothorac Surg, 17, pp.718~722 (2000)
9. Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation", N Engl J Med, 365, pp.883~891 (2011)
10. Connolly SJ, "Dabigatran versus warfarin in patients with atrial fibrillation", N Engl J Med, 361, pp.1139~1151 (2009)
11. Granger CB, "Apixaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 365, pp.981~992 (2011)
12. Boersma LV, "Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry", Eur Heart J, 37, pp.2465~2474 (2016)
13. Madden JL, "Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli", J Am Med Assoc, 140, pp.769~772 (1949)
14. Contractor T, "Left atrial appendage closure in atrial fibrillation: a world without anticoagulation?", Cardiol Res Pract, 2011, pp.752808~ (2011)
15. Healey JS, "Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke", Am Heart J, 150, pp.288~293 (2005)
16. Katz ES, "Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study", J Am Coll Cardiol, 36, pp.468~471 (2000)
17. Kougioumtzoglou AM, "Thoracoscopic left atrial appendage clipping as novel treatment option for peri-device leakage", Europace, 20, pp.955~ (2018)
18. Safavi-Naeini P, "Closure of left atrial appendage to prevent stroke: devices and status", Tex Heart Inst J, 45, pp.172~174 (2018)
19. Thakkar J, "Incidence, prevention, and management of periprocedural complications of left atrial appendage occlusion", Interv Cardiol Clin, 7, pp.243~252 (2018)
20. Messas N, "The amplatzer amulet device: technical considerations and procedural approach", Interv Cardiol Clin, 7, pp.213~218 (2018)
21. Friedman PA, "Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation", J Cardiovasc Electrophysiol, 22, pp.1184~1191 (2011)
22. Mehmet Akif Topcuoglu, "Updates on Prevention of Cardioembolic Strokes", 대한뇌졸중영문학회지, 20(2), pp.180~196 (2018), 대한뇌졸중학회
23. Bayard YL, "Transcatheter occlusion of the left atrial appendage for stroke prevention", Expert Rev Cardiovasc Ther, 3, pp.1003~1008 (2005)
24. Ostermayer SH, "Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials", J Am Coll Cardiol, 46, pp.9~14 (2005)
25. Bayard YL, "PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study", EuroIntervention, 6, pp.220~226 (2010)
26. Park JW, "Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience", Catheter Cardiovasc Interv, 77, pp.700~706 (2011)
27. Tzikas A, "Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug", EuroIntervention, 11, pp.1170~1179 (2016)
28. Lam SC, "Left atrial appendage closure using the Amulet device: an initial experience with the second generation amplatzer cardiac plug", Catheter Cardiovasc Interv, 85, pp.297~303 (2015)
29. Landmesser U, "Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry", EuroIntervention, 14, pp.e590~e597 (2018)
30. Nielsen-Kudsk JE, "Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study", EuroIntervention, 13, pp.371~378 (2017)
31. Cruz-Gonzalez I, "Left atrial appendage occlusion: the current device landscape and future perspectives", Interv Cardiol Clin, 7, pp.253~265 (2018)
32. Bergmann MW, "Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques", EuroIntervention, 10, pp.497~504 (2014)
33. Bellmann B, "Left atrial appendage closure with the New <TEX>$Occlutech^{(R)}$<", TEX> device: first in man experience and neurological outcome, 2017, pp.28, 315~320
34. Park JW, "Left atrial appendage occlusion with Lambre in atrial fibrillation: initial European experience", Int J Cardiol, 265, pp.97~102 (2018)
35. Lakkireddy D, "Short and long-term outcomes of percutaneous left atrial appendage suture ligation: results from a US multicenter evaluation", Heart Rhythm, 13, pp.1030~1036 (2016)
36. Jazayeri MA, "Safety profiles of percutaneous left atrial appendage closure devices: an analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016", J Cardiovasc Electrophysiol, 29, pp.5~13 (2018)
37. Holmes DR, "Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial", Lancet, 374, pp.534~542 (2009)
38. Holmes DR Jr, "Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial", J Am Coll Cardiol, 64, pp.1~12 (2014)
39. Reddy VY, "Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the continued access registry", Circulation, 123, pp.417~424 (2011)
40. Boersma LV, "Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial", Heart Rhythm, 14, pp.1302~1308 (2017)
41. Reddy VY, "Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial", JAMA, 312, pp.1988~1998 (2014)
42. Ezekowitz MD, "Novel anticoagulants eliminate the need for left atrial appendage exclusion devices", Circulation, 130, pp.1505~1514 (2014)
43. Maisel WH, "Left atrial appendage occlusion: closure or just the beginning?", N Engl J Med, 360, pp.2601~2603 (2009)
44. McCabe DJ, "Left atrial appendage occlusion in non-valvular atrial fibrillation", Lancet, 374, pp.504~556 (2009)
45. Waksman R, "Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy", Am J Cardiol, 115, pp.378~384 (2015)
46. Gangireddy SR, "Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit", Eur Heart J, 33, pp.2700~2708 (2012)
47. ACTIVE Investigators, "Effect of clopidogrel added to aspirin in patients with atrial fibrillation", N Engl J Med, 360, pp.2066~2078 (2009)
48. Reddy VY, "Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)", J Am Coll Cardiol, 61, pp.2551~2556 (2013)
49. Yerasi C, "An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion", J Interv Cardiol, 31, pp.197~206 (2018)
50. Hanif H, "Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials", J Cardiovasc Surg (Torino), 59, pp.128~139 (2018)
51. Connolly SJ, "Apixaban in patients with atrial fibrillation", N Engl J Med, 364, pp.806~817 (2011)
52. Reddy VY, "Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial", Circulation, 127, pp.720~729 (2013)
53. Bajaj NS, "Comparison of approaches for stroke prophylaxis in patients with non-valvular atrial fibrillation: network meta-analyses of randomized controlled trials", PLoS One, 11, pp.e0163608~ (2016)
54. Rillig A, "Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imagingdetected brain lesions after percutaneous catheter-based left atrial appendage closure", Heart Rhythm, 15, pp.3~8 (2018)

관련 논문AI추천